logo

Structurally Engineered 3D Printed Architectures for Scalable Tissue Engineering

Location: Netherlands

Source: EU Funding & Tenders Portal

Project
Ended

Engineering tissues with a hierarchical vascular network, which is the goal of our ERC project VascArbor, is challenging. Developments in the field of biofabrication, including 3D bioprinting, are promising to cope with this challenge. However, current strategies lack the capacity to create hierarchical, high resolution, cost efficient, upscalable constructs in a standardized manner with a single

Project Information FAQ

Project Information

3 Q
The project “Structurally Engineered 3D Printed Architectures for Scalable Tissue Engineering” is an infrastructure initiative, located in Netherlands. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

ended

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

Engineering tissues with a hierarchical vascular network, which is the goal of our ERC project VascArbor, is challenging. Developments in the field of biofabrication, including 3D bioprinting, are promising to cope with this challenge. However, current strategies lack the capacity to create hierarchical, high resolution, cost efficient, upscalable constructs in a standardized manner with a single approach. Embedded bioprinting, allowing the deposition of complex constructs without the need of a supporting substrate, provides a potential solution. However, embedding baths used so far consist of inert materials and therefore cannot become a functional component of the tissue. Also, the embedding bath should be patternable to allow for multistructural tissues, but printing of the bath itself is currently challenging due to clogging of the nozzle. SE3DPASTE will develop a dehydrated precursor of a free standing embedding bath that is storable for “off-the-shelf” use and tissue specific. Additionally, SE3DPASTE will develop a bespoke 3D printing nozzle that will allow for the creation of patterned embedding baths. SE3DPASTE will lead to storable, transportable, tissue specific embedding baths that act as a patterning template and can be used for embedded bioprinting of tissue. This combination of features, which does currently not exist in embedding baths for 3D printing, will be a key enabler for the generation of standardized 3D tissue environments that lead to predictable tissue development for research-, clinical-, or drug screening purposes. SE3DPASTE will not only develop the technology to make this possible, but will also take vital steps to bring this technology to the market. By securing the IP, and analyzing the market and the willingness of investors to support SE3DPASTE technology, a fruitful basis for translation will be formed. Finally, this will lead to a business plan providing a roadmap on the necessary future steps to create a market ready product.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data